NYMOX PHARMACEUTICAL CORP

NYMXF · OTCM

CIK 1018735fmd_0YFJA6FKYS5TZS6H3PZK18Z0BNManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2015 to Dec 31, 2025, 33 periods

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).